Latest Breaking News On - Jessica laub - Page 5 : comparemela.com

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesJessica laubAlex braunNicolaus company incBroadridge financial solutionsExchange commissionProspectus departmentAcumen pharmaceuticals incBofa securitiesTryon streetIsland avenueOne montgomery streetAcumen pharmaceuticalsPrivate securities litigation reform actAnnual report

Acumen Pharmaceuticals Announces Proposed Public Offering of Common Stock

Acumen Pharmaceuticals Announces Proposed Public Offering of Common Stock
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesJessica laubicr westwickeAlex braunAcumen pharmaceuticals incProspectus departmentExchange commissionNicolaus company incBroadridge financial solutionsBofa securitiesTryon streetIsland avenueOne montgomery streetAcumen pharmaceuticalsPrivate securities litigation reform actAnnual report

Acumen Pharmaceuticals Presents Positive Topline Results

Topline results from INTERCEPT-AD trial met primary and secondary objectives, demonstrating proof-of-mechanism for ACU193, the first clinical-stage amyloid.

Noord hollandNew yorkUnited statesAlex braunLawrence honigDaniel oconnellSteven dekoskyJessica laubEric siemersUniversity of floridaMcknight brain instituteYork state centerAlzheimer association international conferenceExchange commissionAlzheimer disease at columbia universityResearch session

Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer s Disease at the Alzheimer s Association International Conference (AAIC) 2023

Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer s Disease at the Alzheimer s Association International Conference (AAIC) 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNoord hollandEric siemersAlex braunDaniel oconnellJessica laubSteven dekoskyLawrence honigAlzheimer disease at columbia universityAcumen pharmaceuticalsYork state centerResearch sessionAcumen pharmaceuticals presents positive toplineAcumen pharmaceuticals incMcknight brain institute

Gracell Biotechnologies Presents Updated Data of Deep and Durable Responses for FasTCAR-T GC012F in Relapsed/Refractory Multiple Myeloma at 2023 ASCO Annual Meeting

/PRNewswire/ Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to.

United statesJessica laubWendy liStephanie carringtonMarvin tangFierce life sciences innovationExchange commissionAmerican society of clinical oncologyGracell biotechnologies incPrnewswire gracell biotechnologies incClinical oncologyChief medical officerEuropean hematologyHematologic malignanciesChronic lymphocytic leukemiaInvestigational new drug